Sangamo Therapeutics announced that the FDA has cleared the investigational new drug application for its ST-503 program, an investigational epigenetic regul ...

Contineum Therapeutics, Inc. (NASDAQ: CTNM) (Contineum or the Company), a clinical stage biopharmaceutical company focused on discovering and developi ...

Neuropathic pain refers to pain caused by damage or disease to the nervous system.Neuropathic pain differs in pattern from ...

Patent application paves the way for a potential breakthrough in chronic pain treatment, offering renewed hope for ...